Related Experiment Video

Updated: May 27, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

HCC influence on patient survival after liver transplantation for HDV cirrhosis

Georgios Imvrios1, Dionisios Vrochides, Vasilios Papanikolaou

  • 1Aristotle University, Thessaloniki, Greece.

Hepato-Gastroenterology
|November 17, 2011
PubMed

Insights

Liver transplant recipients with hepatocellular cancer (HCC) for hepatitis B/D virus (HB/DV) cirrhosis showed superior long-term survival. This unexpected finding may be linked to lower infection rates in HCC patients post-transplant.

Area of Science:

  • Hepatology
  • Transplantation immunology
  • Viral hepatitis research

Background:

  • Hepatocellular cancer (HCC) impact on liver transplant outcomes for hepatitis B/D virus (HB/DV) cirrhosis is understudied.
  • HB/DV cirrhosis is a significant indication for liver transplantation worldwide.
  • Understanding HCC's role is crucial for optimizing post-transplant management.

Purpose of the Study:

  • To investigate long-term survival in liver transplant recipients with HB/DV cirrhosis, comparing those with and without HCC.
  • To analyze the influence of HCC on post-transplant outcomes and complications.
  • To identify factors affecting survival in this specific patient cohort.

Main Methods:

  • Retrospective analysis of 231 adult liver transplants (1990-2007).
  • Focus on 27 patients with HB/DV cirrhosis (excluding early post-operative deaths).
  • Median follow-up of 1515 days, comparing outcomes between HCC and non-HCC groups.

Main Results:

  • Mean survival was 3760 days; HCC patients survived longer (4036 days) than non-HCC patients (3011 days).
  • HCC recurrence was not observed in any of the six HCC cases.
  • Microbial infection incidence was lower in HCC patients (33.3%) versus non-HCC patients (61.9%).

Conclusions:

  • Liver transplantation for HB/DV cirrhosis with HCC demonstrates excellent long-term survival exceeding 11 years.
  • The superior survival in HCC patients warrants further investigation.
  • Reduced microbial infections in HCC recipients may contribute to better outcomes.
Abstract

More Related Videos

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...